Funded Tech Companies
DecImmune Therapeutics
Based in Boston, DecImmune Therapeutics raised its funding from Astellas Venture Capital, HealthCare Ventures and Broadview Ventures.
Company Overview
Company Name
DecImmune Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
47 Thorndike St.
Boston, MA 02141
USA
Boston, MA 02141
USA
Phone
Website
Email Address
Company Background Information
Overview
DecImmune Therapeutics is a Boston-based biotech company developing drugs for inflammation and autoimmunity.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
1/17/2013
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Scientific Officer
Walter Newman
Co-Founder
Michael Carroll
Co-Founder
Francis Moore
President
Christopher Mirabelli
Company Investors
- Astellas Venture Capital (Shinya Yano)
- HealthCare Ventures (Christopher Mirabelli)
- Broadview Ventures (Christopher Colecchi)
- Amgen Ventures
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs